scholarly journals 682P Real-world utilization and outcomes of immune-based combination therapies or tyrosine kinase inhibitors (TKIs) for advanced renal cell carcinoma (aRCC)

2021 ◽  
Vol 32 ◽  
pp. S702
Author(s):  
D. Geynisman ◽  
J.K. Kish ◽  
A. Falkenstein ◽  
V. Del Tejo ◽  
B. Stwalley ◽  
...  
Keyword(s):  
Renal Cell Carcinoma ◽  
Tyrosine Kinase ◽  
Cell Carcinoma ◽  
Tyrosine Kinase Inhibitors ◽  
Real World ◽  
Renal Cell ◽  
Kinase Inhibitors ◽  
Advanced Renal Cell Carcinoma ◽  
Combination Therapies

Primary resistance to tyrosine kinase inhibitors in patients with advanced renal cell carcinoma: state-of-the-science

2012 ◽  
Vol 12 (12) ◽  
pp. 1571-1577 ◽  
Author(s):  
Camillo Porta ◽  
Roberto Sabbatini ◽  
Giuseppe Procopio ◽  
Chiara Paglino ◽  
Enzo Galligioni ◽  
...  
Keyword(s):  
Renal Cell Carcinoma ◽  
Tyrosine Kinase ◽  
Cell Carcinoma ◽  
Tyrosine Kinase Inhibitors ◽  
Renal Cell ◽  
Kinase Inhibitors ◽  
Advanced Renal Cell Carcinoma ◽  
Primary Resistance ◽  
State Of The Science

Overall impact of C-reactive protein for advanced renal cell carcinoma treated with tyrosine kinase inhibitors.

2014 ◽  
Vol 32 (15_suppl) ◽  
pp. e15581-e15581
Author(s):  
Tetsuo Fujita ◽  
Ken-ichi Tabata ◽  
Kazumasa Matsumoto ◽  
Daisuke Ishii ◽  
Kazunari Yoshida ◽  
...  
Keyword(s):  
Renal Cell Carcinoma ◽  
Tyrosine Kinase ◽  
Cell Carcinoma ◽  
Tyrosine Kinase Inhibitors ◽  
Renal Cell ◽  
Kinase Inhibitors ◽  
Advanced Renal Cell Carcinoma ◽  
C Reactive Protein ◽  
Reactive Protein
Sign in / Sign up

Export Citation Format

Share Document